Overview
SMi Systems develops super-resolution single molecule imaging platforms for biomedical research and diagnostics. Their integrated system includes instruments, consumables in 96-well formats, and software for automated detection, quantification, and analysis of multiple molecule types. The patented technology enables high-throughput imaging of hundreds of thousands of molecules simultaneously, reducing project timelines and costs.
Frequently asked questions
- What capabilities does SMi Systems' platform offer for pharma R&D?
- The platform provides super-resolution imaging for direct observation of individual molecules, quantification, kinetics data, and multi-omic analysis across diverse molecular targets in standard 96-well formats.
- What regulatory protections does SMi Systems have?
- SMi Systems holds a UK patent (WO2020245579A1) for its single-molecule imaging optical technology from the UK Intellectual Property Office.
- What are the key features of SMi Systems' instruments?
- Instruments offer super-resolution detection over a large field of view, process hundreds of samples in minutes with minimal training, and integrate deep learning for analysis.